{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/hypertension-not-diabetic/diagnosis/diagnosis/","result":{"pageContext":{"chapter":{"id":"7dcedb3e-c4f4-55ff-9910-03ee5ed41bb4","slug":"diagnosis","fullItemName":"Diagnosis","depth":2,"htmlHeader":"<!-- begin field 466a6ed7-1a0c-4ad5-94ce-0b9e8cbd68d4 --><h2>How should I diagnose hypertension?</h2><!-- end field 466a6ed7-1a0c-4ad5-94ce-0b9e8cbd68d4 -->","summary":"","htmlStringContent":"<!-- begin item 88830839-7f15-48e7-a248-fe85fcbc31ea --><!-- begin field b722a8f8-0db4-40dc-9ea0-932000b0eeef --><ul><li><strong>Measure blood pressure in a relaxed, temperate setting, with the person quiet and seated and their arm outstretched and supported. </strong><ul><li>Measure blood pressure in both arms using an appropriate cuff size.<ul><li>If the difference in readings between arms is more than 15 mmHg, repeat the measurements.</li><li>If the difference in readings between arms remains more than 15 mmHg on the second measurement, measure subsequent blood pressures in the arm with the higher reading.</li></ul></li><li>Be aware that automated devices may not measure blood pressure accurately if there is pulse irregularity (for example due to atrial fibrillation).<ul><li>Palpate the radial or brachial pulse before measuring blood pressure. </li><li>If pulse irregularity is present, measure blood pressure manually using direct auscultation over the brachial artery. </li></ul></li><li>In people with symptoms of postural hypotension (falls or postural dizziness), measure blood pressure with the person either supine or seated.<ul><li>Measure blood pressure again with the person standing for at least 1 minute before measurement. </li><li>If the systolic blood pressure falls by 20 mmHg or more when the person is standing, measure subsequent blood pressures with the person standing.</li></ul></li></ul></li><li><strong>If blood pressure measured in the clinic is 140/90 mmHg or higher</strong>, take a second measurement during the consultation.<ul><li>If the second measurement is substantially different from the first, take a third measurement.</li><li>Record the lower of the last 2 measurements as the clinic blood pressure.</li></ul></li><li><strong>If the person's blood pressure is between 140/90 mmHg and 180/120 mmHg, </strong>offer ambulatory blood pressure monitoring (ABPM) to confirm the diagnosis of hypertension. If ABPM is unsuitable or the person is unable to tolerate it, offer home blood pressure monitoring (HBPM).<ul><li><strong>When using ABPM, </strong>ensure that at least 2 measurements per hour are taken during the person's usual waking hours (for example between 8am and 10pm). Use the average value of at least 14 measurements taken during the person's usual waking hours to confirm a diagnosis of hypertension. </li><li><strong>When using HBPM,</strong> ensure that:<ul><li>For each blood pressure recording, 2 consecutive measurements are taken, at least 1 minute apart and with the person seated.</li><li>Blood pressure is recorded twice daily, ideally in the morning and evening.</li><li>Blood pressure recording continues for at least 4 days, ideally for 7 days — discard the measurements taken on the first day and use the average value of all the remaining measurements to confirm the diagnosis of hypertension.</li></ul></li><li><strong>While waiting for confirmation of a diagnosis of hypertension, </strong>carry out investigations for target organ damage, followed by a formal assessment of the person's cardiovascular risk. For more information, see the section on <a class=\"topic-reference internal-reference\" href=\"/topics/hypertension-not-diabetic/diagnosis/investigations/\">Investigations</a>.</li></ul></li><li><strong>If the person's blood pressure is</strong> <strong>180/120 mmHg or higher:</strong><ul><li><strong>Refer for same-day specialist assessment if there are:</strong><ul><li>Signs of retinal haemorrhage and/or papilloedema (<a class=\"topic-reference internal-reference\" href=\"/topics/hypertension-not-diabetic/background-information/definition/\">accelerated hypertension</a>).</li><li>Life-threatening symptoms, such as new onset confusion, chest pain, signs of heart failure, or acute kidney injury. </li></ul></li><li><strong>If there are no symptoms or signs </strong><strong>indicating same-day referral, </strong>carry out <a class=\"topic-reference internal-reference\" href=\"/topics/hypertension-not-diabetic/diagnosis/investigations/\">investigations</a> for target organ damage as soon as possible.<ul><li>If target organ damage is identified, consider starting <a class=\"topic-reference internal-reference\" href=\"/topics/hypertension-not-diabetic/management/management/#antihypertensive-drug-treatment\">antihypertensive drug treatment</a><strong> </strong>immediately, without waiting for the results of ABPM or HBPM.</li><li>If no target organ damage is identified, repeat blood pressure measurement within 7 days. </li></ul></li></ul></li><li><strong>Confirm the diagnosis of hypertension in people with</strong> <strong>a clinic blood pressure of 140/90 mmHg or higher <em>and</em> ABPM daytime average or HBPM average of 135/85 mmHg or higher. </strong><ul><li><strong>Classify the severity of confirmed hypertension using the following criteria:</strong><ul><li>Stage 1 hypertension — clinic blood pressure ranging from 140/90 mmHg to 159/99 mmHg <em>and</em> subsequent ABPM daytime average or HBPM average blood pressure ranging from 135/85 mmHg to 149/94 mmHg.</li><li>Stage 2 hypertension — clinic blood pressure of 160/100 mmHg or higher but less than 180/120 mmHg <em>and</em> subsequent ABPM daytime average or HBPM average blood pressure of 150/95 mmHg or higher.</li><li>Stage 3 or severe hypertension — clinic systolic blood pressure of 180 mmHg or higher <em>or</em> clinic diastolic blood pressure of 120 mmHg or higher.</li></ul></li><li><strong>Suspect <a class=\"topic-reference internal-reference\" href=\"/topics/hypertension-not-diabetic/background-information/definition/\">&#39;white-coat&#39;</a> hypertension </strong>if there is a discrepancy of more than 20/10 mmHg between clinic and average daytime ABPM or average HBPM blood pressure measurements at the time of diagnosis. </li><li><strong>Suspect masked hypertension</strong> if clinic blood pressure measurements are normal (less than 140/90 mmHg) but blood pressure measurements are higher when taken outside the clinic using average daytime ABPM or average HBPM blood pressure measurements.</li></ul></li><li><strong>If hypertension is <em>not</em> diagnosed and:</strong><ul><li><strong>T<strong>here is evidence of target organ damage,</strong> </strong>consider carrying out investigations for alternative causes of the target organ damage. For information on investigations, see CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/chronic-kidney-disease/\">Chronic kidney disease</a> and <a class=\"topic-reference external-reference\" href=\"/topics/heart-failure-chronic/\">Heart failure - chronic</a>.</li><li><strong><strong>There is no evidence of target organ damage,</strong> </strong>measure the person's clinic blood pressure at least every 5 years subsequently, and consider measuring it more frequently if the person's clinic blood pressure is close to 140/90 mmHg.</li></ul></li></ul><p><strong>The National Institute for Health and Care Excellence (NICE) has produced a <a data-hyperlink-id=\"e125ff0d-d584-4624-afbd-aaf1008465ef\" href=\"https://www.nice.org.uk/guidance/ng136/resources/visual-summary-pdf-6899919517\">2-page visual summary on the recommendations for diagnosing and treating hypertension</a>. </strong></p><!-- end field b722a8f8-0db4-40dc-9ea0-932000b0eeef --><!-- end item 88830839-7f15-48e7-a248-fe85fcbc31ea -->","topic":{"id":"c1c1e500-a3f1-5baa-8d5f-890b15f767cc","topicId":"8de59d12-a526-4ab9-8496-1fcb59d838ff","topicName":"Hypertension - not diabetic","slug":"hypertension-not-diabetic","lastRevised":"Last revised in September 2020","chapters":[{"id":"2f82c42a-b82b-549e-9b10-218d9f782bf8","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"a5985652-a8b7-51c0-b2d2-6836d4507f90","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"95f1a40b-c079-5c37-af45-5e0806a2bcae","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"4f16b189-bff9-5dfe-82a9-fdd4cd035ab0","slug":"changes","fullItemName":"Changes"},{"id":"a4dad1ea-40da-5ed2-85b0-8b5ea72bc196","slug":"update","fullItemName":"Update"}]},{"id":"b0107535-58ec-5e22-ac3b-22ae41ade390","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"f76e08e3-badc-526a-835f-8f549cc3f784","slug":"goals","fullItemName":"Goals"},{"id":"928c1147-d56a-5b8a-94f7-87ddad3ef460","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"aae28613-e6a5-5ba1-b4fa-e5032a9918ac","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"7bf8c570-8757-5ae3-802f-5cba9e5ceb86","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"3ace22a3-d042-5a6a-9d63-3527cf484a0a","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"c1a38cc6-4765-5c16-9f08-592cfc9851a3","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"066993d8-fd33-59fb-877b-6e8418b515d1","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"15ade196-5491-5552-9df6-a17d4c9c69d7","slug":"definition","fullItemName":"Definition"},{"id":"4528059a-b33b-51d3-8c65-983b4c165a3a","slug":"prevalence","fullItemName":"Prevalence"},{"id":"3e698434-11c9-553c-96a6-a249bf121cbb","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"0bec257d-f02e-5030-a430-8accc5245e7f","slug":"complications-prognosis","fullItemName":"Complications and prognosis"}]},{"id":"e56e7d7e-9afc-5c38-a77a-8f2b80461457","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"7dcedb3e-c4f4-55ff-9910-03ee5ed41bb4","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"a6466983-7adb-5a4f-8864-f3ecc06b447a","slug":"investigations","fullItemName":"Investigations"}]},{"id":"33227758-4699-5e51-be33-b22dca2eb654","fullItemName":"Management","slug":"management","subChapters":[{"id":"d6332f04-a86e-56ef-9e25-d77083a8371c","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"0cfca07e-cadc-55c1-81ed-fcdb236f4835","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"92190a49-9e8d-5fae-93b2-cf6243cfc01b","slug":"angiotensin-converting-enzyme-inhibitors","fullItemName":"Angiotensin-converting enzyme inhibitors"},{"id":"5ee249d0-bc66-59a5-8138-2449798ff2eb","slug":"angiotensin-ii-receptor-blockers","fullItemName":"Angiotensin-II receptor blockers"},{"id":"115bec24-ba4e-5f2a-80dc-dee6e948a288","slug":"thiazide-type-diuretics","fullItemName":"Thiazide-type diuretics"},{"id":"2ae4ccdd-d119-5a5a-9c89-d6493f2552f2","slug":"calcium-channel-blockers","fullItemName":"Calcium-channel blockers"},{"id":"44681f3b-7958-5edd-a944-eb440f1df250","slug":"spironolactone","fullItemName":"Spironolactone"},{"id":"cb9a67f7-3588-5c68-b3d5-6c63d50ad0b8","slug":"beta-blockers","fullItemName":"Beta-blockers"},{"id":"5740c79c-d5a7-5547-ab38-db87df2b9121","slug":"alpha-blockers","fullItemName":"Alpha-blockers"},{"id":"f3424e7c-5446-59b0-b50e-0724587bb306","slug":"covid-19","fullItemName":"COVID-19"}]},{"id":"3b3191c9-bff5-563f-b5c0-09e8a0d22441","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"7d204db0-8ff2-556e-97b4-89516ac7819b","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"0f686cda-dcaf-5f12-b5d6-871aefae47fe","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"dfcaec55-3c23-5a3f-9c08-f151a3120dc2","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"804073cd-b49f-5e4a-bf85-90faf125ad0e","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"613e4289-93db-5311-aa87-b5a7a6e82dd1","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"6e42a873-c39f-5405-bf4f-efdd81187ea2","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"2b87bc1c-2b4a-556b-b320-6b4f18bcf85d","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"e56e7d7e-9afc-5c38-a77a-8f2b80461457","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"babc2e09-854a-525e-9313-1357e8fc439e","slug":"basis-for-recommendation-3ae","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field 1d626b2d-a55d-4698-be39-a71600c9111a --><h3>Basis for recommendation</h3><!-- end field 1d626b2d-a55d-4698-be39-a71600c9111a -->","summary":null,"htmlStringContent":"<!-- begin item 3ae8bffd-1f1a-404a-8787-a71600c9109a --><!-- begin field 4a671241-e021-4ccd-befb-a71600c9111a --><p>These recommendations are based on the National Institute for Health and Care Excellence (NICE) guideline <em>Hypertension in adults: diagnosis and management </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypertension-not-diabetic/references/\">NICE, 2019</a>]. For information on why NICE made these recommendations and how they might affect practice, see the section on <a href=\"https://www.nice.org.uk/guidance/ng136/resources/hypertension-in-adults-diagnosis-and-management-pdf-66141722710213\" data-hyperlink-id=\"25937438-2d7a-4a16-807c-aaf1006a82e7\">Rationale and impact</a> in the NICE guideline <em>Hypertension in adults: diagnosis and management </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypertension-not-diabetic/references/\">NICE, 2019</a>].</p><!-- end field 4a671241-e021-4ccd-befb-a71600c9111a --><!-- end item 3ae8bffd-1f1a-404a-8787-a71600c9109a -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}